CN111388682A - cMLCK基因导入 - Google Patents

cMLCK基因导入 Download PDF

Info

Publication number
CN111388682A
CN111388682A CN202010310166.9A CN202010310166A CN111388682A CN 111388682 A CN111388682 A CN 111388682A CN 202010310166 A CN202010310166 A CN 202010310166A CN 111388682 A CN111388682 A CN 111388682A
Authority
CN
China
Prior art keywords
leu
glu
gly
ala
cmlck
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010310166.9A
Other languages
English (en)
Chinese (zh)
Inventor
周明东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zensun Shanghai Science and Technology Ltd
Original Assignee
Zensun Shanghai Science and Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zensun Shanghai Science and Technology Ltd filed Critical Zensun Shanghai Science and Technology Ltd
Priority to CN202010310166.9A priority Critical patent/CN111388682A/zh
Publication of CN111388682A publication Critical patent/CN111388682A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11018—Myosin-light-chain kinase (2.7.11.18)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
CN202010310166.9A 2015-05-08 2015-05-08 cMLCK基因导入 Pending CN111388682A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010310166.9A CN111388682A (zh) 2015-05-08 2015-05-08 cMLCK基因导入

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010310166.9A CN111388682A (zh) 2015-05-08 2015-05-08 cMLCK基因导入
CN201510232415.6A CN106177992A (zh) 2015-05-08 2015-05-08 cMLCK基因导入

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201510232415.6A Division CN106177992A (zh) 2015-05-08 2015-05-08 cMLCK基因导入

Publications (1)

Publication Number Publication Date
CN111388682A true CN111388682A (zh) 2020-07-10

Family

ID=57247711

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202010310166.9A Pending CN111388682A (zh) 2015-05-08 2015-05-08 cMLCK基因导入
CN201510232415.6A Pending CN106177992A (zh) 2015-05-08 2015-05-08 cMLCK基因导入
CN201680025125.7A Pending CN107735109A (zh) 2015-05-08 2016-06-14 cMLCK基因导入

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201510232415.6A Pending CN106177992A (zh) 2015-05-08 2015-05-08 cMLCK基因导入
CN201680025125.7A Pending CN107735109A (zh) 2015-05-08 2016-06-14 cMLCK基因导入

Country Status (10)

Country Link
US (1) US20180133291A1 (cg-RX-API-DMAC7.html)
EP (1) EP3295959A4 (cg-RX-API-DMAC7.html)
JP (1) JP2018515510A (cg-RX-API-DMAC7.html)
KR (1) KR20190008511A (cg-RX-API-DMAC7.html)
CN (3) CN111388682A (cg-RX-API-DMAC7.html)
AU (1) AU2016260473A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017024065A2 (cg-RX-API-DMAC7.html)
CA (1) CA2985396A1 (cg-RX-API-DMAC7.html)
RU (1) RU2017142779A (cg-RX-API-DMAC7.html)
WO (1) WO2016180377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun (Shanghai)Science & Technology Limited Compositions and methods for treating heart failure
RU2650635C2 (ru) 2012-10-08 2018-04-16 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. Композиции и способы лечения сердечной недостаточности у пациентов с диабетом
CN111388682A (zh) * 2015-05-08 2020-07-10 上海泽生科技开发股份有限公司 cMLCK基因导入
CN115838437A (zh) * 2022-11-04 2023-03-24 广州达安基因股份有限公司 人NT-proBNP融合蛋白及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242388A (ja) * 2008-03-14 2009-10-22 National Cardiovascular Center 心臓特異的キナーゼの心不全診断および治療への応用
CN102416184A (zh) * 2011-12-08 2012-04-18 哈尔滨医科大学 microRNA-1的反义锁核苷酸序列在制备预防或治疗心肌梗死后心衰药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375185B2 (en) * 2000-09-12 2008-05-20 The United States Of America As Represented By The Department Of Health And Human Services Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use
US9580515B2 (en) * 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
CN111388682A (zh) * 2015-05-08 2020-07-10 上海泽生科技开发股份有限公司 cMLCK基因导入

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242388A (ja) * 2008-03-14 2009-10-22 National Cardiovascular Center 心臓特異的キナーゼの心不全診断および治療への応用
CN102416184A (zh) * 2011-12-08 2012-04-18 哈尔滨医科大学 microRNA-1的反义锁核苷酸序列在制备预防或治疗心肌梗死后心衰药物中的应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
杨 楠等: "MLCK 在慢性心力衰竭中作用机制的研究" *

Also Published As

Publication number Publication date
EP3295959A1 (en) 2018-03-21
RU2017142779A (ru) 2019-06-10
KR20190008511A (ko) 2019-01-24
JP2018515510A (ja) 2018-06-14
CA2985396A1 (en) 2016-11-17
CN106177992A (zh) 2016-12-07
CN107735109A (zh) 2018-02-23
WO2016180377A1 (zh) 2016-11-17
AU2016260473A1 (en) 2017-12-21
RU2017142779A3 (cg-RX-API-DMAC7.html) 2019-12-03
US20180133291A1 (en) 2018-05-17
BR112017024065A2 (pt) 2018-08-07
EP3295959A4 (en) 2019-01-02

Similar Documents

Publication Publication Date Title
AU2007221470B2 (en) Phosphatase inhibitor Protein-1 as a regulator of cardiac function
AU2004204815B2 (en) Method for in vivo regulation of cardiac muscle contractility
CN102618562B (zh) 生长因子神经调节蛋白的下游蛋白纽激酶
US20130035282A1 (en) Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide
US20180133291A1 (en) Cmlck gene transfer
AU2004291809B2 (en) Method of growing myocardial cells
CN114616001A (zh) 用于治疗人骨关节炎的基于腺病毒的生物递送和表达系统的有效剂量以及包含其的组合物
JP2002514908A (ja) うっ血性心不全のための遺伝子治療
US20090105148A1 (en) Compositions and methods for treating myocardial infarction
TW201200151A (en) Methods and compositions related to reduced MET phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
US20070265221A1 (en) Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure
US20050026233A1 (en) Methods of monitoring and modulating LKB1 activity and its downstream targets
US20030148952A1 (en) Methods and materials for the recruitment of endothelial cells
US20230250450A1 (en) NRF2 Activator for Use in Treating Dilated Cardiomyopathies
WO2001000825A2 (en) Human chromosome 15 and 16 bardet-biedl syndrome polynucleotides and polypeptides and methods of use
US20120245221A1 (en) Anti-apoptotic agents and uses thereof
CA2293733A1 (en) Mycardium-and skeletal muscle-specific nucleic acid, its preparation and use
HK1129392A (en) Phosphatase inhibitor protein-1 as a regulator of cardiac function
JP2013531990A (ja) アテローム性動脈硬化症治療のための組成物および方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200710

WD01 Invention patent application deemed withdrawn after publication